Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Viking Therapeutics Inc’s stock clocked out at $23.60, up 2.12% from its previous closing price of $23.11. In other words, the price has increased by $2.12 from its previous closing price. On the day, 3.36 million shares were traded. VKTX stock price reached its highest trading level at $23.83 during the session, while it also had its lowest trading level at $22.52.
Ratios:
To gain a deeper understanding of VKTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 33.09 and its Current Ratio is at 33.09. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 08, 2025, initiated with a Neutral rating and assigned the stock a target price of $30.
On February 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $102.
On February 07, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $38.Citigroup initiated its Neutral rating on February 07, 2025, with a $38 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 31 ’25 when Rouan Sarah Kathryn bought 1,240 shares for $24.15 per share. The transaction valued at 29,943 led to the insider holds 1,240 shares of the business.
Lian Brian sold 194,490 shares of VKTX for $8,313,601 on Jan 06 ’25. The President & CEO now owns 2,366,570 shares after completing the transaction at $42.75 per share. On Jan 06 ’25, another insider, Mancini Marianna, who serves as the Chief Operating Officer of the company, sold 54,215 shares for $42.75 each. As a result, the insider received 2,317,599 and left with 374,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 2650020352 and an Enterprise Value of 1747555328.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.80, which has changed by -0.6350703 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $81.86, while it has fallen to a 52-week low of $18.92. The 50-Day Moving Average of the stock is -14.69%, while the 200-Day Moving Average is calculated to be -50.71%.
Shares Statistics:
It appears that VKTX traded 4.73M shares on average per day over the past three months and 5496240 shares per day over the past ten days. A total of 111.57M shares are outstanding, with a floating share count of 108.98M. Insiders hold about 2.94% of the company’s shares, while institutions hold 73.35% stake in the company. Shares short for VKTX as of 1743379200 were 25618104 with a Short Ratio of 5.42, compared to 1740700800 on 23912963. Therefore, it implies a Short% of Shares Outstanding of 25618104 and a Short% of Float of 27.38.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
